Ligand · WVI
WVI · 3-methyl-4-(thiophen-2-yl)-1H-pyrazol-5-amine
WVI, 3-methyl-4-(thiophen-2-yl)-1H-pyrazol-5-amine (C8 H9 N3 S, 179.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the…
- Component
- WVI
- Formula
- C8 H9 N3 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
WVI in 2 structures; the first of them:
- 4BDH · Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase… · WVI A1514 · binds LEU226, VAL234, ALA247, LEU301, GLU302, LEU303, MET304, GLU308 and 2 more
- 4BDH · Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase… · WVI A1514 · binds LEU226, VAL234, ALA247, LEU301, GLU302, LEU303, MET304, GLU308 and 2 more
Residues it binds most
LEU 2, GLU 2, ALA 2, MET 2, THR 2, VAL 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.